Patents by Inventor CLAUDIA KIRSTENPFAD

CLAUDIA KIRSTENPFAD has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-HLA-G ANTIBODIES AND USE THEREOF
    Publication number: 20210147553
    Abstract: The present invention relates to anti-HLA-G antibodies and methods of using the same.
    Type: Application
    Filed: October 16, 2020
    Publication date: May 20, 2021
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Stefan DENGL, Sebastian FENN, Jens FISCHER, Andreas HINZ, Claudia KIRSTENPFAD, Stefan KLOSTERMANN, Joerg MOELLEKEN, Georg TIEFENTHALER, Sabine HOVES, Alexander BUJOTZEK, Meher MAJETY
  • MULTISPECIFIC ANTIBODIES AND USE THEREOF
    Publication number: 20210147554
    Abstract: The present invention relates to multispecific antibodies that bind to HLA-G ant to a T cell activating antigen, their preparation, formulations and methods of using the same.
    Type: Application
    Filed: October 16, 2020
    Publication date: May 20, 2021
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Stefan DENGL, Sebastian FENN, Jens FISCHER, Claudia KIRSTENPFAD, Stefan KLOSTERMANN, Joerg MOELLEKEN, Georg TIEFENTHALER, Alexander BUJOTZEK, Meher MAJETY, Silke KIRCHNER
  • ANTI-HLA-G ANTIBODIES AND USE THEREOF
    Publication number: 20200102389
    Abstract: The present invention relates to anti-HLA-G antibodies and methods of using the same.
    Type: Application
    Filed: May 17, 2019
    Publication date: April 2, 2020
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Jens FISCHER, Meher MAJETY, Stefan DENGL, Georg TIEFENTHALER, Stefan KLOSTERMANN, Claudia KIRSTENPFAD, Esther KOENIGSBERGER, Francesca ROS
  • COMBINATION THERAPY OF AN AFUCOSYLATED ANTIBODY AND ONE OR MORE OF THE CYTOKINES GM CSF, M CSF AND/OR IL3
    Publication number: 20100247484
    Abstract: The present invention is directed to the combination therapy of an afucosylated antibody specifically binding to a tumor-antigen with one or more cytokines selected from the group of human GM-CSF, human M-CSF and/or human IL-3 for the treatment of cancer.
    Type: Application
    Filed: March 29, 2010
    Publication date: September 30, 2010
    Inventors: HEINRICH BARCHET, GEORG FERTIG, CLAUDIA KIRSTENPFAD